Navigation Links
Feinstein Institute collaborates with GSK, UPenn, MIT to research body's electrical impulses
Date:4/10/2013

MANHASSET, NY The Feinstein Institute for Medical Research today unveiled a collaboration with the University of Pennsylvania and Massachusetts Institute of Technology (MIT) being spearheaded by GlaxoSmithKline (GSK), which aims to discover medicines that use electrical impulses to regulate the body's organs and functions. This initiative is discussed in the April issue of Nature.

"This is a powerful collaboration between leaders in the field of medical device development," said Kevin J. Tracey, MD, president of the Feinstein Institute. "We are focused on developing implantable electrical devices as treatments for disease. It is likely that miniaturized, computerized technologies that target neurons will someday replace existing drugs this has the potential to be revolutionize how we think about helping patients."

Nearly all organs and functions in the body are regulated through circuits of neurons that communicate through electrical impulses. There already exist devices that use electrical impulses to treat disease (i.e., pacemakers, defibrillators, deep-brain stimulation), but these devices do not target specific cells in the body. Researchers now believe it is possible to create devices that control action potentials in individual neurons, a critical step in developing technologies to use neural circuits to control specific cells. It may be possible to intervene in a broad spectrum of diseases, like inflammatory and autoimmune diseases, because these conditions can be controlled by neurons.

The collaboration between the Feinstein Institute, GSK, MIT and University of Pennsylvania will dedicate resources with the aim to discover electrical impulse medical treatment (electroceuticals). Specifically, the Feinstein Institute will continue research on the neural codes that underlie diseases of immunity and inflammation to identify intervention points and conduct exploratory clinical work. Initial results have already shown that it is possible to manipulate neural signals specific to different inflammatory mediators in standard laboratory models.


'/>"/>

Contact: Emily Eng
eng3@nshs.edu
516-562-2670
North Shore-Long Island Jewish (LIJ) Health System
Source:Eurekalert

Related biology news :

1. Feinstein Institute receives $1 million grant to study impact of World Trade Center attacks on responders
2. DOE Joint Genome Institute 8th Annual Meeting on March 26-28, 2013
3. Forsyth Institute receives $4.1 million grant for new center
4. Harvards Wyss Institute and Sony DADC announce collaboration on Organs-on-Chips
5. Sanford-Burnham Medical Research Institute and Mayo Clinic extend collaborative agreement
6. RayBiotech, Inc. Executes Neuroscience Biomarker Master Services Agreement with Banner Sun Health Research Institute
7. Scripps Research Institute study shows how brain cells shape temperature preferences
8. Salk Institute awarded historic $42 million grant from the Helmsley Charitable Trust
9. La Jolla Institute identifies molecular switch enabling immune cells to better fight disease
10. NJIT and Chinese Tech Institute join forces for 2013 Solar Decathlon in China
11. UTSA engineer Hai-Chao Han named Fellow of Medical and Biological Engineering Institute
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2016)... , June 2, 2016 The Department ... has awarded the 44 million US Dollar project, for the ... Vehicle Plates including Personalization, Enrolment, and IT Infrastructure , ... in the production and implementation of Identity Management Solutions. Numerous ... however Decatur was selected for the ...
(Date:6/1/2016)... -- Favorable Government Initiatives Coupled With Implementation ... to Boost Global Biometrics System Market Through 2021  ... " Global Biometrics Market By Type, By End ... - 2021", the global biometrics market is projected to ... growing security concerns across various end use sectors such ...
(Date:5/16/2016)... NEW YORK , May 16, 2016   ... authentication solutions, today announced the opening of an IoT ... to strengthen and expand the development of embedded ... provides an unprecedented level of convenience and security with ... to authenticate one,s identity aside from DNA. EyeLock,s platform ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... - FACIT has announced the creation of a ... Propellon Therapeutics Inc. ("Propellon" or "the Company"), to ... of first-in-class WDR5 inhibitors for the treatment of ... an exciting class of therapies, possessing the potential ... patients. Substantial advances have been achieved with the ...
(Date:6/23/2016)... 23, 2016  The Biodesign Challenge (BDC), a university ... to harness living systems and biotechnology, announced its winning ... New York City . ... showcased projects at MoMA,s Celeste Bartos Theater during the ... MoMA,s senior curator of architecture and design, and ...
(Date:6/23/2016)... LOUISVILLE, Ky. , June 23, 2016 /PRNewswire/ ... from two Phase 1 clinical trials of its ... double-blind, placebo-controlled, single and multiple ascending dose studies ... and pharmacodynamics (PD) of subcutaneous injection in healthy ... APL-2 subcutaneously (SC) either as a single dose ...
(Date:6/23/2016)... ... June 23, 2016 , ... Regulatory Compliance Associates® ... provides a free webinar on Performing Quality Investigations: Getting to Root ... CT at no charge. , Incomplete investigations are still a major concern to ...
Breaking Biology Technology: